Breaking News Instant updates and real-time market news.

AIRI

Air Industries

/

+

10:11
08/08/22
08/08
10:11
08/08/22
10:11

Air Industries reports Q2 revenue $14M vs. $15.5M last year

Lou Melluzzo, CEO of Air Industries said, "The Company continued to make progress in the second quarter of 2022 - a challenging period during which, like most manufacturing businesses, we faced significant supply chain disruptions affecting the availability of raw materials. Nevertheless, comparing our 2022 second quarter performance to this year's first quarter, which reflected a similar operating environment, net sales were up 16%, consolidated gross profit was up nearly 17%, and operating income rose nearly 20%. The raw material delays and delays in outside processing, regrettably, impeded the production of some customer orders, which largely contributed to the decrease in sales compared with the year-ago quarter and six month periods. That said, the recent periods demonstrate the advantages of Air Industries' diverse mix of stable aircraft product platforms and customers. While sales declined overall for the first half of 2022 versus 2021, we experienced solid increases in some platforms, namely the Northrup Grumman E2-D, and the Pratt & Whitney Geared Turbo Fan. We also saw increased volume of assemblies for the Sikorsky CH-53 helicopter. We are working diligently to address the current challenging environment. In particular, we are continuing our vertical integration strategy, which is designed to improve efficiency and shorten production times. Our in-house painting facility is up and running, and undergoing qualification, and we are establishing a function at our Sterling operation that should facilitate the assembly process for a substantial customer order The long-term prospects for our marketplace are strong. We attended the recent Farnborough Airshow, one of the key events for the aerospace industry, where the tone was generally upbeat. For example, demand remains substantial for the Lockheed Martin F-35 Joint Strike Fighter, which is the best-in-world fifth-generation fighter aircraft, and the fighter aircraft program of record for allied militaries around the globe. We are continuing to position Air Industries for enhanced performance in our growing industry through investments in vertically integrated processes and capital equipment to make us an even more valuable partner to our aerospace and defense customers, while pursuing expanded business development and sales efforts."

  • 08

    Aug

OTHER BREAKING NEWS FROM THE FLY

Earnings
Canadian Pacific reports Q4 adjusted EPS C$1.14 vs C$0.96 last year » 16:05
01/31/23
01/31
16:05
01/31/23
16:05
CP

Canadian Pacific

$78.78 /

+1.46 (+1.89%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

01/24/23 Scotiabank
Canadian Pacific price target raised to C$110 from C$102 at Scotiabank
01/11/23 Barclays
Canadian Pacific price target raised to $86 from $81 at Barclays
12/16/22 National Bank
Canadian Pacific price target raised to C$106 from C$105 at National Bank
12/14/22 CIBC
Canadian Pacific price target raised to C$130 from C$120 at CIBC
CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

CP Canadian Pacific
$78.78 /

+1.46 (+1.89%)

Hot Stocks
Prothena reports 'positive' topline Phase 1 study results for PRX005 » 16:05
01/31/23
01/31
16:05
01/31/23
16:05
PRTA

Prothena

$56.23 /

+1.25 (+2.27%)

, BMY

Bristol-Myers

$72.48 /

+0.45 (+0.62%)

Prothena Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

PRTA Prothena
$56.23 /

+1.25 (+2.27%)

01/27/23 Piper Sandler
Prothena initiated with an Overweight at Piper Sandler
12/21/22 Cantor Fitzgerald
Prothena price target raised to $98 from $91 at Cantor Fitzgerald
11/29/22 Jefferies
Prothena data from AD/PD abstract 'promising,' says Jefferies
11/15/22 Oppenheimer
Prothena price target raised to $120 from $110 at Oppenheimer
BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
12/23/22 William Blair
NccRCC 'material expansion opportunity' for Exelixis, says William Blair
11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

  • 15
    Dec
BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

PRTA Prothena
$56.23 /

+1.25 (+2.27%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

BMY Bristol-Myers
$72.48 /

+0.45 (+0.62%)

Earnings
Credit Acceptance reports Q4 EPS $11.74, consensus $7.16 » 16:05
01/31/23
01/31
16:05
01/31/23
16:05
CACC

Credit Acceptance

$465.61 /

+12.45 (+2.75%)

Reports Q4 revenue $…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CACC Credit Acceptance
$465.61 /

+12.45 (+2.75%)

CACC Credit Acceptance
$465.61 /

+12.45 (+2.75%)

11/03/22 BMO Capital
Credit Acceptance price target lowered to $364 from $477 at BMO Capital
11/02/22 Credit Suisse
Credit Acceptance price target lowered to $410 from $430 at Credit Suisse
08/02/22 Credit Suisse
Credit Acceptance price target lowered to $440 from $460 at Credit Suisse
05/03/22 Credit Suisse
Credit Acceptance price target raised to $460 from $440 at Credit Suisse
CACC Credit Acceptance
$465.61 /

+12.45 (+2.75%)

Hot Stocks
Electronic Arts delays 'Star Wars Jedi: Survivor' launch to April 28 » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
EA

Electronic Arts

$128.45 /

-0.58 (-0.45%)

EA announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

EA Electronic Arts
$128.45 /

-0.58 (-0.45%)

Earnings
Hawaiian Holdings reports Q4 adjusted EPS (49c), consensus (70c) » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
HA

Hawaiian Holdings

$12.25 /

+0.485 (+4.12%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HA Hawaiian Holdings
$12.25 /

+0.485 (+4.12%)

HA Hawaiian Holdings
$12.25 /

+0.485 (+4.12%)

12/20/22 Deutsche Bank
Hawaiian Holdings price target lowered to $13 from $17 at Deutsche Bank
12/16/22 Goldman Sachs
Hawaiian Holdings resumed with a Sell at Goldman Sachs
10/06/22 BofA
Hawaiian Holdings price target lowered to $10 from $12 at BofA
08/15/22 Melius Research
Hawaiian Holdings initiated with a Hold at Melius Research
HA Hawaiian Holdings
$12.25 /

+0.485 (+4.12%)

HA Hawaiian Holdings
$12.25 /

+0.485 (+4.12%)

Earnings
Central Garden & Pet affirms FY23 EPS view of $2.60-$2.80, consensus $2.66 » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
CENTA

Central Garden & Pet

$39.72 /

+1.27 (+3.30%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CENTA Central Garden & Pet
$39.72 /

+1.27 (+3.30%)

01/13/23 JPMorgan
Central Garden & Pet price target lowered to $39 from $40 at JPMorgan
10/13/22 JPMorgan
Central Garden & Pet price target lowered to $37 from $45 at JPMorgan
08/25/22 CJS Securities
Central Garden & Pet initiated with an Outperform at CJS Securities
08/08/22 Truist
Central Garden & Pet price target lowered to $60 from $65 at Truist
CENTA Central Garden & Pet
$39.72 /

+1.27 (+3.30%)

Periodicals
Apple shopping ad packages for MLS Season Pass for $4M/season, Bloomberg says » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
AAPL

Apple

$143.15 /

+0.14 (+0.10%)

As Apple launches MLS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$143.15 /

+0.14 (+0.10%)

AAPL Apple
$143.15 /

+0.14 (+0.10%)

05:56 Today UBS
Apple iPhone sell-through down 12% in Q4, says UBS
01/30/23 Wells Fargo
Wells Fargo near-term cautious on Apple into upcoming Q1 earnings
01/30/23 Credit Suisse
Credit Suisse remains bullish on Apple, sees potential upside to estimates
01/27/23 Evercore ISI
Evercore has increased confidence Apple's March guide will top consensus
AAPL Apple
$143.15 /

+0.14 (+0.10%)

AAPL Apple
$143.15 /

+0.14 (+0.10%)

AAPL Apple
$143.15 /

+0.14 (+0.10%)

AAPL Apple
$143.15 /

+0.14 (+0.10%)

Hot Stocks
Tubi signs content deal with Warner Bros. Discovery » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
FOX

Fox Corp.

$31.62 /

+0.21 (+0.67%)

, WBD

Warner Bros. Discovery

$14.74 /

+0.37 (+2.57%)

, FOXA

Fox Corp.

$33.88 /

+0.24 (+0.71%)

Tubi announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOX Fox Corp.
$31.62 /

+0.21 (+0.67%)

WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

FOX Fox Corp.
$31.62 /

+0.21 (+0.67%)

07:04 Today Morgan Stanley
Fox Corp. resumed with an Equal Weight at Morgan Stanley
01/06/23 MKM Partners
MKM Partners sees WWE as 'very attractive asset' if it goes for sale
06/02/22 Wolfe Research
Fox Corp. assumed at Peer Perform from Outperform at Wolfe Research
04/19/22 Rosenblatt
Fox Corp. initiated with a Neutral at Rosenblatt
WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

06:53 Today Macquarie
Warner Bros. Discovery price target raised to $20 from $16 at Macquarie
01/30/23 Morgan Stanley
Warner Bros. Discovery price target raised to $17 from $14 at Morgan Stanley
01/24/23 Atlantic Equities
Atlantic sees 80% upside in Warner Bros. Discovery after analyzing merger
01/11/23 Guggenheim
Guggenheim upgrades Warner Bros. Discovery to Buy, sees 31% potential upside
FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

07:04 Today Morgan Stanley
Fox Corp. resumed with an Equal Weight at Morgan Stanley
01/25/23 Loop Capital
Fox upgraded to Buy with $40 price target at Loop Capital
01/25/23 Loop Capital
Loop upgrades News Corp. to Buy on ending of Fox tie-up
01/25/23 Loop Capital
Fox Corp. upgraded to Buy from Hold at Loop Capital
FOX Fox Corp.
$31.62 /

+0.21 (+0.67%)

WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

FOX Fox Corp.
$31.62 /

+0.21 (+0.67%)

WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

FOX Fox Corp.
$31.62 /

+0.21 (+0.67%)

WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

WBD Warner Bros. Discovery
$14.74 /

+0.37 (+2.57%)

FOXA Fox Corp.
$33.88 /

+0.24 (+0.71%)

Earnings
Electronic Arts cuts FY23 EPS view to $2.97-$3.11 from $3.11-$3.34 » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
EA

Electronic Arts

$128.51 /

-0.52 (-0.40%)

Consensus $7.16. Cuts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

EA Electronic Arts
$128.51 /

-0.52 (-0.40%)

Earnings
Central Garden & Pet reports Q1 EPS (16c), consensus (17c) » 16:04
01/31/23
01/31
16:04
01/31/23
16:04
CENTA

Central Garden & Pet

$39.56 /

+1.11 (+2.89%)

Reports Q1 revenue $628M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CENTA Central Garden & Pet
$39.56 /

+1.11 (+2.89%)

01/13/23 JPMorgan
Central Garden & Pet price target lowered to $39 from $40 at JPMorgan
10/13/22 JPMorgan
Central Garden & Pet price target lowered to $37 from $45 at JPMorgan
08/25/22 CJS Securities
Central Garden & Pet initiated with an Outperform at CJS Securities
08/08/22 Truist
Central Garden & Pet price target lowered to $60 from $65 at Truist
CENTA Central Garden & Pet
$39.56 /

+1.11 (+2.89%)

Hot Stocks
Amgen sees FY23 CapEx about $925M » 16:03
01/31/23
01/31
16:03
01/31/23
16:03
AMGN

Amgen

$252.45 /

+0.88 (+0.35%)

FY23 share repurchases…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$252.45 /

+0.88 (+0.35%)

AMGN Amgen
$252.45 /

+0.88 (+0.35%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$252.45 /

+0.88 (+0.35%)

AMGN Amgen
$252.45 /

+0.88 (+0.35%)

AMGN Amgen
$252.45 /

+0.88 (+0.35%)

AMGN Amgen
$252.45 /

+0.88 (+0.35%)

Earnings
Electronic Arts sees Q4 EPS 5c-20c, consensus $2.22 » 16:03
01/31/23
01/31
16:03
01/31/23
16:03
EA

Electronic Arts

$128.68 /

-0.35 (-0.27%)

Sees Q4 net bookings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

Earnings
Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 » 16:02
01/31/23
01/31
16:02
01/31/23
16:02
AMGN

Amgen

$252.39 /

+0.82 (+0.33%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

Earnings
Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33 » 16:02
01/31/23
01/31
16:02
01/31/23
16:02
AMGN

Amgen

$252.39 /

+0.82 (+0.33%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

AMGN Amgen
$252.39 /

+0.82 (+0.33%)

Earnings
Electronic Arts reports Q3 EPS 73, consensus $3.05 » 16:02
01/31/23
01/31
16:02
01/31/23
16:02
EA

Electronic Arts

$128.68 /

-0.35 (-0.27%)

Reports Q3 net bookings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

EA Electronic Arts
$128.68 /

-0.35 (-0.27%)

General news
December farm prices up 22.0% vs. last year  16:01
01/31/23
01/31
16:01
01/31/23
16:01
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
December farm prices up 3.1% vs. last month  16:01
01/31/23
01/31
16:01
01/31/23
16:01
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Amgen reports Q4 adjusted EPS $4.09, consensus $4.09 » 16:01
01/31/23
01/31
16:01
01/31/23
16:01
AMGN

Amgen

$252.23 /

+0.66 (+0.26%)

Reports Q4 revenue $6.8B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$252.23 /

+0.66 (+0.26%)

AMGN Amgen
$252.23 /

+0.66 (+0.26%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$252.23 /

+0.66 (+0.26%)

AMGN Amgen
$252.23 /

+0.66 (+0.26%)

AMGN Amgen
$252.23 /

+0.66 (+0.26%)

AMGN Amgen
$252.23 /

+0.66 (+0.26%)

Hot Stocks
Kushner says $18.50 offer for Veris Residential remains outstanding » 16:01
01/31/23
01/31
16:01
01/31/23
16:01
VRE

Veris Residential

$17.16 /

+0.26 (+1.54%)

Kushner, which identifies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRE Veris Residential
$17.16 /

+0.26 (+1.54%)

VRE Veris Residential
$17.16 /

+0.26 (+1.54%)

01/19/23 BTIG
BTIG continues to see value in Veris Residential
12/13/22 BTIG
Veris Residential price target lowered to $22 from $26 at BTIG
11/14/22 BofA
Veris Residential upgraded to Neutral at BofA in residential REIT repositioning
11/14/22 BofA
Veris Residential upgraded to Neutral from Underperform at BofA
VRE Veris Residential
$17.16 /

+0.26 (+1.54%)

VRE Veris Residential
$17.16 /

+0.26 (+1.54%)

VRE Veris Residential
$17.16 /

+0.26 (+1.54%)

Hot Stocks
FFBW Inc trading halted, news pending  16:01
01/31/23
01/31
16:01
01/31/23
16:01
 
Conference/Events
JPMorgan Mexican strategist to hold analyst/industry conference call » 15:59
01/31/23
01/31
15:59
01/31/23
15:59

Mexico Equity Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Target says Omaha West store closed until further notice following incident » 15:57
01/31/23
01/31
15:57
01/31/23
15:57
TGT

Target

$171.76 /

+3.08 (+1.83%)

Target issued the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$171.76 /

+3.08 (+1.83%)

TGT Target
$171.76 /

+3.08 (+1.83%)

01/23/23 Oppenheimer
Target initiated with an Outperform at Oppenheimer
01/04/23 Wells Fargo
Wells Fargo downgrades Target to Equal Weight, lowers price target to $142
01/04/23 Wells Fargo
Target downgraded to Equal Weight from Overweight at Wells Fargo
12/21/22 Gordon Haskett
Gordon Haskett downgrades Target on 'meaningfully eroded' traffic
TGT Target
$171.76 /

+3.08 (+1.83%)

TGT Target
$171.76 /

+3.08 (+1.83%)

TGT Target
$171.76 /

+3.08 (+1.83%)

TGT Target
$171.76 /

+3.08 (+1.83%)

Recommendations
Wolters Kluwer price target lowered to EUR 120 from EUR 125 at Barclays » 15:53
01/31/23
01/31
15:53
01/31/23
15:53
WTKWY

Wolters Kluwer

$108.24 /

+0.805 (+0.75%)

Barclays analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WTKWY Wolters Kluwer
$108.24 /

+0.805 (+0.75%)

WTKWY Wolters Kluwer
$108.24 /

+0.805 (+0.75%)

01/18/23 Credit Suisse
Wolters Kluwer price target lowered to EUR 115 from EUR 116 at Credit Suisse
12/16/22 Morgan Stanley
Wolters Kluwer price target raised to EUR 129 from EUR 126 at Morgan Stanley
12/12/22 JPMorgan
Wolters Kluwer price target lowered to EUR 108 from EUR 113 at JPMorgan
12/01/22 Exane BNP Paribas
Wolters Kluwer downgraded to Underperform from Neutral at Exane BNP Paribas
Recommendations
Vivendi price target raised to EUR 12.50 from EUR 12.20 at Barclays » 15:53
01/31/23
01/31
15:53
01/31/23
15:53
VIVHY

Vivendi

$10.72 /

-0.02 (-0.19%)

Barclays analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$10.72 /

-0.02 (-0.19%)

01/20/23 Morgan Stanley
Vivendi price target raised to EUR 13.60 from EUR 13.40 at Morgan Stanley
12/16/22 Morgan Stanley
Vivendi price target raised to EUR 13.40 from EUR 12.30 at Morgan Stanley
12/12/22 JPMorgan
Vivendi price target lowered to EUR 12.30 from EUR 13.40 at JPMorgan
10/24/22 AlphaValue/Baader
Vivendi downgraded to Add from Buy at AlphaValue/Baader
Recommendations
Stroeer price target raised to EUR 54 from EUR 47.50 at Barclays » 15:53
01/31/23
01/31
15:53
01/31/23
15:53
SOTDY

Stroeer

$18.00 /

+ (+0.00%)

Barclays analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOTDY Stroeer
$18.00 /

+ (+0.00%)

01/18/23 Exane BNP Paribas
Stroeer downgraded to Underperform from Outperform at Exane BNP Paribas
12/02/22 JPMorgan
Stroeer price target raised to EUR 46 from EUR 41 at JPMorgan
11/14/22 UBS
Stroeer price target lowered to EUR 60 from EUR 62 at UBS
11/11/22 Barclays
Stroeer price target lowered to EUR 47.50 from EUR 53 at Barclays

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.